End-of-day quote
Shanghai S.E.
23:00:00 25/04/2024 BST
|
5-day change
|
1st Jan Change
|
22.87
CNY
|
+3.06%
|
|
+6.37%
|
-34.56%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
17,756
|
17,278
|
15,761
|
11,852
|
10,093
|
10,093
|
-
|
Enterprise Value (EV)
1 |
17,756
|
17,278
|
15,761
|
11,852
|
15,423
|
10,093
|
10,093
|
P/E ratio
|
94.2
x
|
61.6
x
|
49.8
x
|
36.8
x
|
65.9
x
|
22.4
x
|
16.2
x
|
Yield
|
-
|
-
|
0.6%
|
-
|
0.79%
|
-
|
-
|
Capitalization / Revenue
|
14.1
x
|
10.3
x
|
7.8
x
|
-
|
8.3
x
|
4.09
x
|
3.15
x
|
EV / Revenue
|
14.1
x
|
10.3
x
|
7.8
x
|
-
|
8.3
x
|
4.09
x
|
3.15
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
33.8
x
|
20.3
x
|
15.1
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
4.57
x
|
-
|
3.93
x
|
2.35
x
|
2.12
x
|
Nbr of stocks (in thousands)
|
401,000
|
438,537
|
439,387
|
440,592
|
441,301
|
441,301
|
-
|
Reference price
2 |
44.28
|
39.40
|
35.87
|
26.90
|
22.87
|
22.87
|
22.87
|
Announcement Date
|
26/02/20
|
22/04/21
|
27/02/22
|
27/02/23
|
26/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,264
|
1,677
|
2,020
|
-
|
1,857
|
2,466
|
3,202
|
EBITDA
1 |
-
|
-
|
-
|
-
|
299
|
496
|
667
|
EBIT
1 |
-
|
-
|
310.4
|
-
|
252.4
|
454
|
625
|
Operating Margin
|
-
|
-
|
15.37%
|
-
|
13.59%
|
18.41%
|
19.52%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
317.9
|
-
|
251.5
|
456
|
626
|
Net income
1 |
178.2
|
-
|
314
|
323.1
|
233.5
|
452
|
619
|
Net margin
|
14.1%
|
-
|
15.54%
|
-
|
12.57%
|
18.33%
|
19.33%
|
EPS
2 |
0.4700
|
0.6400
|
0.7200
|
0.7300
|
0.5300
|
1.020
|
1.410
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
0.2150
|
-
|
0.1800
|
-
|
-
|
Announcement Date
|
26/02/20
|
22/04/21
|
27/02/22
|
27/02/23
|
26/02/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
13.7%
|
-
|
9.5%
|
-
|
5.96%
|
10.5%
|
13%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
4.23%
|
-
|
4.8%
|
7.5%
|
9.1%
|
Assets
1 |
-
|
-
|
7,422
|
-
|
5,371
|
6,027
|
6,802
|
Book Value Per Share
2 |
-
|
-
|
7.850
|
-
|
8.890
|
9.740
|
10.80
|
Cash Flow per Share
2 |
-
|
-
|
0.6000
|
-
|
1.270
|
-
|
-
|
Capex
1 |
-
|
-
|
318
|
-
|
178
|
150
|
150
|
Capex / Sales
|
-
|
-
|
15.75%
|
-
|
9.86%
|
6.08%
|
4.68%
|
Announcement Date
|
26/02/20
|
22/04/21
|
27/02/22
|
27/02/23
|
26/02/24
|
-
|
-
|
Last Close Price
22.87
CNY Average target price
41
CNY Spread / Average Target +79.27% Consensus |
1st Jan change
|
Capi.
|
---|
| -34.56% | 1.39B | | +6.56% | 32.91B | | +17.38% | 8.1B | | -2.71% | 6.98B | | +20.18% | 5.45B | | -3.97% | 4.13B | | +34.04% | 3.95B | | +5.47% | 3.4B | | -9.99% | 2.72B | | +8.20% | 2.43B |
Testing & Measuring Equipment
|